Aavant Research
Finnrick has tested 18 samples from Aavant Research across 2 products.
Take Action
Request Full Data Access to the Finnrick database of peptide tests.
Products
| Tests | ||||||||
|---|---|---|---|---|---|---|---|---|
| Product | Rating | Count | Avg | Min | Max | Oldest | Most Recent | |
| Retatrutide | 7 | 11 Aug 2025 | 3 Mar 2026 | |||||
| Tirzepatide | 11 | 24 Oct 2025 | 20 May 2026 | |||||
The Aavant Research samples tested by Finnrick were either acquired by Finnrick directly, or submitted by the public.
Most recent Aavant Research tests
Samples are tested in commercial labs
tests
products
Scores
First
Last
| Quantity | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Product | Certificate | Test Score | Label | Batch | Tested | Difference | Purity | Endotoxins | Batch ID | Container | Tested At | Sent By |
| 20 May 2026 | Tirzepatide | View | 30mg | (no batch claim) | 30.4mg | +1.3% | 99.90% | n/a | 967284-000012 | Silver label / Silver crimp / Gray cap | Lab E | Public | |
| 28 Apr 2026 | Tirzepatide | View | 30mg | (no batch claim) | 33.2mg | +10.7% | 99.90% | below LOQ | 967284-000012 | No Label / Silver Crimp / Gray Cap | Lab E | Public | |
| 25 Mar 2026 | Tirzepatide | View | 15mg | (no batch claim) | 17.7mg | +18.0% | 99.70% | n/a | 967296-000001 | Silver Label / Silver Crimp / Violet Cap | Lab G | Public | |
| 25 Mar 2026 | Tirzepatide | View | 30mg | (no batch claim) | 35.5mg | +18.3% | 99.90% | n/a | 967284-000011 | Silver Label / Black Crimp / Pink Cap | Lab G | Public | |
| 3 Mar 2026 | Retatrutide | View | 24mg | 25.7mg | 24.9mg | -3.3% | 99.86% | n/a | 967285-000006 | No Label / Silver Crimp / Red Cap | Lab E | Public | |
| 2 Mar 2026 | Tirzepatide | View | 30mg | 31.9mg | 34.9mg | +9.3% | 99.90% | n/a | 967284-000002 | No Label / Silver Crimp / Red Cap | Lab E | Public | |
| 11 Feb 2026 | Retatrutide | View | 12mg | (no batch claim) | 13.4mg | +11.7% | 99.90% | n/a | 967286-000004 | Silver Label / Silver Crimp / Black Cap | Lab E | Public | |
About Aavant Research Test Results From Finnrick
Aavant Research is a peptide vendor with multiple products tracked in the independent testing dataset collected by Finnrick. This page compiles recent, batch-level test results across 2 products and 18 tests, including scores, test dates, batch IDs, and lab details. This enables you to compare quality over time, not just marketing claims.
Each tested sample receives a 0–10 score, with 10 being the best possible value. It is the total of three components: purity (0–4 points), quantity accuracy vs. the label or batch claim (0–4 points), and batch information quality (0–2 points).
When several test results are available for a product and vendor pair, you’ll also find a Finnrick Rating (A–E, where A is best and E is worst, X if an insufficient number of tests is available, or F in rare cases of documented and widespread fraud). Use the table above to review purity, quantity accuracy, consistency between batches, and any notable outliers surfaced in Finnrick testing data.
Aavant Research Testing Activity & Score Summary
In the past 30 days, Finnrick has published 1 new test result for Aavant Research, and 6 in the past three months. The overall dataset includes 18 tested samples with an average score of 8.6/10 across all products.
Across 18 identity-tested samples, 100% were confirmed to contain the expected peptide (identity pass rate). Among those that passed, median purity was 99.8%. Approximately 100% of passing samples tested at or above 98% purity.
Here is a closer look at the most frequently tested products (top 2):
- Tirzepatide (11 tests, 100% identity pass, median purity 99.9%) — Test scores are highly variable, ranging from 6.8 to 10.0 (average 8.8/10), suggesting significant batch-to-batch differences.
- Retatrutide (7 tests, 100% identity pass, median purity 99.8%) — Test scores are highly variable, ranging from 6.2 to 9.5 (average 8.3/10), suggesting significant batch-to-batch differences.